Thema: US47973J1025
JYNT, US47973J1025
wall-street-582921_1920.jpg - Foto: THN
The Joint stock heads into earnings release after market close
The company will publish its third-quarter results after the U.S. market close. Management will discuss the figures and business outlook during a webcast.
ad-hoc-news.de, vor 57 Minuten
JYNT, US47973J1025
The Joint reacquires Texas rights: what it means for The ...
Second-quarter revenue rose 14.40 percent to USD 15.18 million. For The Joint stock, the plan covers over 150 clinic opportunities.
ad-hoc-news.de, 16.10.26 05:12 Uhr
JYNT, US47973J1025
The Joint stock fell 1.04 percent as Texas rights reshape ...
The Joint stock regained Texas development rights linked to more than 150 clinic opportunities on October 6, 2026. Q2 revenue rose 14.4 percent year over year.
ad-hoc-news.de, 07.10.26 06:44 Uhr
JYNT, US47973J1025
The Joint reacquires Texas rights for USD 8.00 million: ...
Texas includes 141 clinics and sellers retain eight under the October 1 deal. USD 102.4 million values The Joint stock as of October 5, 2026.
ad-hoc-news.de, 06.10.26 08:15 Uhr
Investors, Await
Investors Await Joint Corp.’s Annual Report for Strategic ...
Joint US47973J1025
boerse-global.de, 09.02.26 22:03 Uhr
The, Joint
The Joint Corp: A Stock at a Critical Juncture
